Drug Rehab Chapel Hill Nc Navigation


Drug Rehab Chapel Hill Nc

|

Partners
Tell A Friend about us
Drug Treatment Dogs |
Alcohol Treatment Gateshead |
Alcohol And Drug Research |
Alcohol Treatment In Phoenix Az |
Aetna Drug Rehab Coverage |
Marijuana Addiction Treatment Ontario |
Drug Rehab Luton |
Drug Treatment Kuroyume |
Drug Rehab In Managua, Nicaragua |
Drug Rehab 77008 |
Drug Treatment Class Marijuana Possession |
Drug Treatment Washington Dc |
North Carolina Drug Rehab |
Drug Rehab Advanced Treatment For Chemical Dependency |
Drug Rehab Eureka |

List of Drug-Alcohol-Treatment Articles

Drug Rehab Chapel Hill Nc Best Seller



Best Drug Rehab Chapel Hill Nc Products

Social bookmarking
You like it? Share it!
socialize it


Main Drug Rehab Chapel Hill Nc Sponsors


Drug Rehab Chapel Hill Nc

 

Latest Drug Rehab Chapel Hill Nc Link Added

Top 5 Drug and Alcohol Treatment Pages

1. Drug Rehab
2. Drug Alcohol
3. Drug Treatment
4. Drug Addiction
5. Alcohol Treatment




Submit your link on Drug Rehab Chapel Hill Nc!


Welcome to Drug and Alcohol Treatment


 

Drug Rehab Chapel Hill Nc Article

Thumbnail example

This is a selection made from among articles on Drug Rehab Chapel Hill Nc. For a permanent link to this article, or to bookmark it for future reading, click here.

from: Alcohol and Drug Rehab: Triggers, Cravings, Relapse and Recovery




Alcohol and Drug Rehab: Triggers, Cravings, Relapse and Recovery
By Jonathan Huttner




It has taken some time but, researchers have come to the conclusion that drug addiction and alcoholism are diseases and like other diseases, are chronic and those afflicted are subject to relapse. From a medical perspective, addiction can be compared to diabetes in that it will require long term treatment, lifestyle changes, medication at times and if not monitored, relapse will occur.



Experts with The National Institute of Drug Abuse feel it is not reasonable to expect a recovering addict or alcoholic to maintain lifelong abstinence with just one treatment or rehab experience. Furthermore, Dr. George Koob, a professor with the Scripps Research Institute agrees. His research has shown that approximately 80 percent of the addicts and alcoholics who experience detox return to drug or alcohol use within a year.



Discovering why addicts and alcoholics are so prone to relapse is an area of great concern to all of us. One aspect we identified is that of craving. Craving is the incredible desire an addict or alcoholic still feels for the substance days, months or even years into recovery. Research has shown us that the cravings that the addict or alcoholic experience could be directly related to the long term changes in brain function, due to the drug and alcohol abuse. In essence, the brain has become conditioned to function under the influence of drugs or alcohol and does not function efficiently without it.



Secondly, it has been established that cravings can be a conditioned response to triggers that the recovering addict or alcoholic may encounter, for example old people, places or things associated with the person’s prior drug or alcohol use. Relapse triggers, as they are termed, can create powerful emotional and sometimes physical responses that can lead up to incredible urges to use drugs and alcohol again. It is for this reason individuals early in sobriety are urged to change so many aspects of their life. With all of this said, it is clear that a person’s relapse is usually preceded by other difficulties which result in the addict or alcoholic feeling angry, lonely, depressed or in self pity.



The issue with relapse that is infinitely grave is not necessarily the fact that the addict or alcoholic has used or drank again, but the quantity and frequency with which they use is almost identical to right before they began their recovery. Very few, ease their way back into their drug or alcohol use. They begin as if they never stopped.



An experiment performed by Dr. Koob demonstrated that when alcohol was removed from alcoholic or addicted rats for three or four days and then returned, the rats consumed 50 percent more drugs or alcohol as they consumed before. As common as this behavior is among the people that relapse, it is one of the most misunderstood.



There is good news and that is if a relapse is caught early, it can prove to be a very valuable educational tool. The recovering addict or alcoholic might then practice the principles taught to them in their alcohol and drug rehab program with more willingness and motivation than ever before.



It appears that for those people that are able to maintain long term recovery from drug addiction and alcoholism the solution is much greater than just abstaining from drugs and alcohol. The other part of the equation lies in being able to identify cravings, wait out the feelings and become aware of what actually triggered them. Through becoming aware of what triggers the craving, the recovering person can make effective changes in their “life style” which can result in fewer urges to drink or drug. Finally, there are a number of well-known alcohol and drug rehab support groups that provide much needed support to help addicts (and their families) cope with the long term issues associated with drug addiction and alcoholism.




Jonathan Huttner is one of the the principals at Lakeview Health Systems, an addiction treatment, alcohol and drug rehab facility. Addiction treatment information and free live help 24/7 is being provided online at RecoveryConnection.org.



Article Source: http://EzineArticles.com/?expert=Jonathan_Huttner
http://EzineArticles.com/?Alcohol-and-Drug-Rehab:-Triggers,-Cravings,-Relapse-and-Recovery&id=154938









Drug Rehab Chapel Hill Nc Specific links

Drug Rehab Chapel Hill Nc News

POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial Results - MarketWatch (press release)


POZEN Reports PA32540 / PA8140 Updates and First Quarter 2012 Financial Results
MarketWatch (press release)
CHAPEL HILL, NC, May 01, 2012 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ:POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2012.
How arthritis drug Vimovo could ease Pozen's PA32540 regulatory painMedCity News

all 10 news articles »

Read more...


Cempra, Inc. Reports First Quarter 2012 Financial and Operating Results - MarketWatch (press release)


Cempra, Inc. Reports First Quarter 2012 Financial and Operating Results
MarketWatch (press release)
CHAPEL HILL, NC, May 10, 2012 /PRNewswire via COMTEX/ -- Cempra, Inc. (NASDAQ:CEMP) , a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...

and more »

Read more...


Australia: No deal was made in Indonesia drug case - WRAL.com


WRAL.com

Australia: No deal was made in Indonesia drug case
WRAL.com
But Foreign Minister Bob Carr conceded that Indonesians saw a link between the treatment of Australian Schapelle Corby and young Indonesians held in Australian prisons. Corby, 34, learned in a Bali prison on Tuesday that Indonesian President Susilo ...

and more »

Read more...


In CH, Hagan Touts Easier Access To New Med Treatment - Chapelboro.com


Chapelboro.com

In CH, Hagan Touts Easier Access To New Med Treatment
Chapelboro.com
CHAPEL HILL - US Senator Kay Hagan (D-NC) will be in Chapel Hill Tuesday, meeting with patients at the NC Children's Hospital to gather support for the TREAT Act, a bill that she says will make it easier for patients with rare diseases to get better, ...

and more »

Read more...


BellBrook Labs' Transcreener ADP Assay Aids in the Fight Against Antibiotic ... - San Francisco Chronicle (press release)


BellBrook Labs' Transcreener ADP Assay Aids in the Fight Against Antibiotic ...
San Francisco Chronicle (press release)
Recently researchers at The University of North Carolina at Chapel Hill overcame this roadblock by using BellBrook Labs' Transcreener ADP Assay as an exquisitely sensitive ATPase Assay, allowing them to identify novel RecA inhibitors that were active ...

and more »

Read more...


Pozen migraine drug licensed to Desitin for commercialization in Europe - MedCity News


Pozen migraine drug licensed to Desitin for commercialization in Europe
MedCity News
Pozen licensed the compound MT 400 to German central nervous system therapies company Desitin in a deal that will pay the Chapel Hill, North Carolina drug developer $3 million up front, plus milestones and royalties from drug sales in the 27 European ...

and more »

Read more...


Chapel Hill man found guilty in 2008 execution-style slaying - WRAL.com


WRAL.com

Chapel Hill man found guilty in 2008 execution-style slaying
WRAL.com
Hillsborough, NC — An Orange County jury on Tuesday found a Chapel Hill man guilty of first-degree murder in the July 2008 execution-style shooting death of 20-year-old Joshua McCabe Bailey. Brian Gregory Minton, 22, was also found guilty of ...

and more »

Read more...


Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and ... - MarketWatch (press release)


Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and ...
MarketWatch (press release)
CHAPEL HILL, NC, May 3, 2012 /PRNewswire via COMTEX/ -- Cempra, Inc. (NASDAQ:CEMP) today announced that it will report first quarter 2012 financial results and provide a business update after the close of US financial markets on May 10, 2012.

and more »

Read more...


Prostate cancer and the PSA test: It's hard to understand risk - Los Angeles Times


Prostate cancer and the PSA test: It's hard to understand risk
Los Angeles Times
Noel Brewer, an associate professor of health behavior at the University of North Carolina in Chapel Hill and member of the US Food and Drug Administration's Risk Communication Advisory Committee, compared the phenomenon to riding a roller coaster.

and more »

Read more...


NHLBI Funds UNC Diabetes PGx Project - GenomeWeb


NHLBI Funds UNC Diabetes PGx Project
GenomeWeb
By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – University of North Carolina at Chapel Hill researchers have won a $2.4 million grant to study genetic variations in diabetes patients in order to predict response to treatment and reduce ...

and more »

Read more...